Skip to content

NHUMEDICS

Active
Private limited companyfounded 20233 yrs activeBeurtstraat 91, 3390 Tielt-Winge, BelgiumKBO/BCE: BE 0803.970.345
Summary

The computed 12-month bankruptcy probability of NHUMEDICS is 2.9% (moderate). The 2024 annual accounts show equity of €278,631 and a net result of €187,010. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
Axes · tick = 2023
Profitability100=
Solvency100▲+4
Growth78
Track record94
Bankruptcy probability, 12 months
2.9% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €22,000 at 30 days acceptable
Liquidity ample (current ratio 5.36 against 3.38 in 2023; short-term debt: 18.6% and cash: 37.7% of total assets), and 18.6% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 3 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
81.4%
Return on assets
54.6%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-07-2025, 0 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
not confirmed
2024
on the day
2023
13 d late
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 2 accounts on average 7 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

NHUMEDICS was incorporated on 14 July 2023 as a Private limited company.1 The company has filed 2 sets of annual accounts, the latest for fiscal year 2024.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€278,631▲ 204%
2023 · €91,621
Total assets
€342,409▲ 164%
2023 · €129,745
Net result
€187,010▲ 111%
2023 · €88,621
Working capital
€277,953▲ 206%
2023 · €90,762
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20232024
Operating result€123,860-€244,886▲ 97.7%
Net result€88,621-€187,010▲ 111%
Equity€91,621-€278,631▲ 204%
Total assets€129,745-€342,409▲ 164%
Debt€38,124-€63,778▲ 67.3%
Working capital€90,762-€277,953▲ 206%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100,000€200,000Operating result 2023: €123,860€123,860Net result 2023: €88,621€88,621Operating result 2024: €244,886€244,886Net result 2024: €187,010€187,01020232024€0€100,000€200,000Operating result 2023: €123,860€124,000Net result 2023: €88,621€88,600Operating result 2024: €244,886€245,000Net result 2024: €187,010€187,00020232024
The operating result rises in 2024; 2024 is 98% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €342,409
Fixed assets €679 ▼ 20.9%
Current assets €341,731 ▲ 165%
Equity and liabilities €342,409
Equity €278,631 ▲ 204%
Debt €63,778 ▲ 67.3%
Debt's share of the balance-sheet total falls from 29.4% to 18.6%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€245,066▲
2023 · €123,901
Cash flow
€187,190▲
2023 · €88,661
Current ratio
5.36▲
2023 · 3.38
Debt to equity
0.23▼
2023 · 0.42
ROE
67.1%▼
2023 · 96.7%
ROA
54.6%▼
2023 · 68.3%
Interest coverage
3819.00▼
2023 · 4720.03
Debt ≤ 1 year
€63,778▲
2023 · €38,124
Income taxes
€58,136▲
2023 · €35,366
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,275 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
2.2% stopped otherwise
96% still going

A further 0.4% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a higher bankruptcy probability: 2.9% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,275 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 36 lines
Balance sheet Code20232024
Assets
Total assets20/58€129,745€342,409▲
Fixed assets21/28€859€679▼
Tangible fixed assets22/27€859€679▼
Furniture and vehicles24€859€679▼
Current assets29/58€128,886€341,731▲
Amounts receivable within one year40/41€2,965€5,058▲
Other amounts receivable41€2,965€5,058▲
Current investments50/53-€60,000
Cash at bank and in hand54/58€31,402€129,075▲
Deferred charges and accrued income490/1€94,519€147,598▲
Equity and liabilities
Total equity and liabilities10/49€129,745€342,409▲
Equity10/15€91,621€278,631▲
Contributions10/11€3,000€3,000=
Reserves13€88,621€275,631▲
Distributable reserves133€88,621€275,631▲
Amounts payable17/49€38,124€63,778▲
Amounts payable within one year42/48€38,124€63,778▲
Trade debts44€2,758€5,665▲
Suppliers440/4€2,758€5,665▲
Taxes, remuneration and social security45€35,366€58,113▲
Taxes450/3€35,366€58,113▲
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€40€180▲
Other operating charges640/8€342€370▲
Gross operating margin9900€124,243€245,435▲
Operating profit (loss)9901€123,860€244,886▲
Financial income75/76B€153€325▲
Recurring financial income75€153€325▲
Financial charges65/66B€26€64▲
Recurring financial charges65€26€64▲
Profit (loss) for the period before taxes9903€123,987€245,147▲
Income taxes67/77€35,366€58,136▲
Profit (loss) for the period9904€88,621€187,010▲
Profit (loss) for the period to be appropriated9905€88,621€187,010▲
Appropriation of the result
Profit (loss) to be appropriated9906€88,621€187,010▲
Transfer to equity691/2€88,621€187,010▲
To other reserves6921€88,621€187,010▲

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20232024Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€40€180▲ 345%
Other operating charges640/8€342€370▲ 8.2%
Gross operating margin9900€124,243€245,435▲ 97.5%
Operating profit (loss)9901€123,860€244,886▲ 97.7%
Financial income75/76B€153€325▲ 113%
Recurring financial income75€153€325▲ 113%
Financial charges65/66B€26€64▲ 144%
Recurring financial charges65€26€64▲ 144%
Profit (loss) for the period before taxes9903€123,987€245,147▲ 97.7%
Income taxes67/77€35,366€58,136▲ 64.4%
Profit (loss) for the period9904€88,621€187,010▲ 111%
Profit (loss) for the period to be appropriated9905€88,621€187,010▲ 111%
Line20232024Change
Assets
Total assets20/58€129,745€342,409▲ 164%
Fixed assets21/28€859€679▼ 20.9%
Tangible fixed assets22/27€859€679▼ 20.9%
Furniture and vehicles24€859€679▼ 20.9%
Current assets29/58€128,886€341,731▲ 165%
Amounts receivable within one year40/41€2,965€5,058▲ 70.6%
Other amounts receivable41€2,965€5,058▲ 70.6%
Current investments50/53-€60,000-
Cash at bank and in hand54/58€31,402€129,075▲ 311%
Deferred charges and accrued income490/1€94,519€147,598▲ 56.2%
Equity and liabilities
Total equity and liabilities10/49€129,745€342,409▲ 164%
Equity10/15€91,621€278,631▲ 204%
Contributions10/11€3,000€3,000=
Reserves13€88,621€275,631▲ 211%
Distributable reserves133€88,621€275,631▲ 211%
Amounts payable17/49€38,124€63,778▲ 67.3%
Amounts payable within one year42/48€38,124€63,778▲ 67.3%
Trade debts44€2,758€5,665▲ 105%
Suppliers440/4€2,758€5,665▲ 105%
Taxes, remuneration and social security45€35,366€58,113▲ 64.3%
Taxes450/3€35,366€58,113▲ 64.3%
Line20232024Change
Profit (loss) for the period9904€88,621€187,010▲ 111%
+ Depreciation and write-downs630€40€180▲ 345%
Operating cash flow (approximation)€88,661€187,190▲ 111%
Investment in fixed assets (approximation)-€0-
Change in cash-€97,673-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
31-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Equity above €200,000Eq €278,631 ▲204%
2 profitable years in a row build equity to €278,631.
13-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 13 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tielt-Winge · 1 establishment unit since 2023
seat establishment The establishment unit on the map
Ground area
3.0 ha
Building footprint
8,930 m²
Volume, LiDAR
110,495 m³
2 parcels, Flanders · tallest building 22.7 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
NHUMEDICS
Pastoor Paquaylaan 129, 3550 Heusden-ZolderSpecialist medical practice
since 20232.347.426.328
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71025A0073/00H101 Flanders 3.0 ha 1 · 8,828 m² 22.7 m · 5 fl.
24106F0259/00F002 Flanders 907 m² 1 · 102 m² 10.8 m · 3 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded14-07-2023
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:0803970345
Also 9925:BE0803970345
Registered 05-11-2024

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.